查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1948740

疫苗管瓶监测器市场 - 全球产业规模、份额、趋势、机会及按类型、应用、地区和竞争格局分類的预测（2021-2031年）

Vaccine Vial Monitor Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Multi-Dose, Single Dose), By Application (Preventive Vaccine, Therapeutics Vaccine), By Region & Competition, & Competition 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球疫苗管瓶监测器市场预计将从 2025 年的 2.4116 亿美元成长到 2031 年的 3.9149 亿美元，复合年增长率为 8.41%。

这些监测器作为疫苗管瓶上的感温变色标籤，能够以不可逆的视觉方式显示疫苗的累积受热情况，并在疫苗超过其稳定性极限时发出讯号。该行业的主要驱动力是国际卫生组织强制执行的严格低温运输合规标准，以及在分发过程中减少疫苗浪费的迫切营运需求。这些根本驱动因素，而非技术趋势，源自于确保在储存基础设施不可靠和气候条件极端恶劣的地区疫苗有效性和安全性的内在要求。

市场概览
预测期 2027-2031
市场规模：2025年 2.4116亿美元
市场规模：2031年 3.9149亿美元
复合年增长率：2026-2031年 8.41%
成长最快的细分市场 多剂量
最大的市场 北美洲

市场扩张的一大障碍在于生产能够在各种环境下稳定运作的化学指示剂成本高且技术复杂。近期一些机构的统计数据清楚地显示了这些监测设备所需的物流规模。例如，全球疫苗免疫联盟（Gavi）在2024年发布的报告显示，其支持的低收入国家在2023年将有6900万儿童参与常规免疫接种活动，这凸显了对温度敏感的产品数量庞大，需要有效的监测解决方案来维护供应链的完整性。

市场驱动因素

全球免疫和疫苗倡议的扩展是疫苗管瓶监测器市场的主要驱动力，直接增加了大规模宣传活动活动所需的监测器数量。随着国际卫生组织加强在偏远地区防治可预防疾病，对单一管瓶进行温度检验以确保运输安全的需求日益增长。大规模干预措施充分体现了这项需求的激增。例如，全球疫苗免疫联盟（Gavi）于2024年11月宣布，将支持一项针对24个国家多达1亿名儿童的免疫接种追踪宣传活动，其中包括麻疹疫苗。这项活动将需要数百万个带有疫苗瓶监测器标籤的疫苗瓶，以确保疫苗在接种时的有效性。

同时，严格的低温运输监管标准的引入正在重塑市场需求，强制要求在基础设施建设的同时进行严格的温度监控。加强开发中地区的低温运输是先进监控工具可靠运作的先决条件，这些工具需要在改进的系统中运行，并最大限度地减少浪费。根据联合国儿童基金会于2024年4月发布的《2023年度供应报告》，该组织与非洲疾病管制与预防中心合作，已向30多个国家提供了价值2,500万美元的低温运输设备。这些投资凸显了对品质保证的重视，鑑于疫苗覆盖率缺口不断扩大，这一点至关重要。 2024年7月，世界卫生组织指出，到2023年，完全未接种任何疫苗的儿童人数（「零剂量」）将达到1450万，凸显了可靠的疫苗供应机制存在巨大的未满足需求。

市场挑战

生产稳定的化学指示剂成本高且技术复杂，是限制全球疫苗管瓶监测市场成长的主要阻碍因素。製造能够精确响应累积热暴露的感温变色标籤需要复杂的化学工程技术，这必然会推高生产成本，并增加新製造商的进入门槛。这些高昂的营运成本会转化为更高的单位成本，使得在预算严格控制的开发中地区，成本敏感型采购专案难以采用这项技术。因此，这些监测器的高成本迫使相关人员限制其使用或探索其他品管方法，从而降低了整体市场渗透率。

随着医药物流领域的扩张，成本障碍日益凸显。随着分销网络的扩张，为数百万新增产品单元应用昂贵的监控解决方案所带来的累积财务负担，对供应链决策者而言是一个重大阻碍。国际航空运输协会（IATA）的数据显示，2024年4月全球航空货运需求年增11.1%，显示需要温控的货物量增加。物流吞吐量的激增进一步加剧了製造成本上涨的影响。监控日益增多的产品单元所需的投资，阻碍了这些关键指标的广泛应用。

市场趋势

随着物联网智慧疫苗管瓶监测器的推出，市场正在发生变革，监测功能从简单的颜色变化视觉监测发展到即时数据记录。这些数位指示器将关键的稳定性数据传输到云端平台，使相关人员能够在劣化之前进行干预，并详细了解整个低温运输的运输状态。这项技术飞跃超越了传统的化学标籤，能够精确追踪个体疫苗的完整性。对这种自动化监测的需求正在成长。根据斑马技术公司于2024年5月发布的《医院愿景调查》，84%的非临床医院管理人员优先考虑为床边给药的药品整合自动化数位化库存追踪系统。

同时，监测技术的应用范围正从免疫接种计画扩展到疫苗以外的其他对温度敏感的药品领域。随着业界推动复杂生物製药和基因疗法的研发，对严格温度检验的需求也扩展到更广泛的高价值资产类别，以保护易受影响的治疗药物以及疫苗。这种多元化需求正在推动对能够保护昂贵特药的多功能指标的需求。这项转变的规模令人瞩目：根据医疗保健分销联盟 (HDA) 研究基金会 2024 年 3 月发布的报告《美国药品低温运输的未来》，从 2018 年到 2024 年，对温度敏感的产品的增长率比低温运输疗法高出 21%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球疫苗管瓶监测器市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（多剂量、单剂量）
    • 依用途（预防性疫苗、治疗性疫苗）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美疫苗管瓶监测器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲疫苗管瓶监测器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区疫苗管瓶监测器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲疫苗管瓶监测器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美疫苗管瓶监测器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球疫苗管瓶监测器市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Cardinal Health Inc
  • Catalent Inc
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • Elpro-Buchs AG
  • EVIGENCE SENSORS Inc
  • Gerresheimer AG
  • Schott AG
  • Thermo Fisher Scientific Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 17604

The Global Vaccine Vial Monitor Market is projected to expand from USD 241.16 Million in 2025 to USD 391.49 Million by 2031, registering a CAGR of 8.41%. These monitors function as thermochromic labels on vaccine vials, offering an irreversible visual indication of cumulative heat exposure to signal when a vaccine has surpassed its stability limit. The industry is primarily underpinned by strict cold chain compliance standards enforced by international health bodies and the critical operational need to reduce vaccine wastage during distribution. These fundamental drivers are distinct from technological trends, stemming instead from the essential requirement to guarantee vaccine potency and safety in regions plagued by unreliable storage infrastructure or extreme climatic conditions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 241.16 Million
Market Size 2031USD 391.49 Million
CAGR 2026-20318.41%
Fastest Growing SegmentMulti-Dose
Largest MarketNorth America

A major obstacle to broader market expansion is the significant cost and technical complexity involved in producing stable chemical indicators that perform consistently across diverse environments. The logistical magnitude required for these monitors is highlighted by recent organizational statistics. For instance, Gavi, the Vaccine Alliance, reported in 2024 that routine immunization efforts in supported lower-income countries reached 69 million children in 2023, underscoring the substantial volume of temperature-sensitive units that require effective monitoring solutions to maintain supply chain integrity.

Market Driver

The expansion of global immunization and vaccination initiatives serves as a primary catalyst for the Vaccine Vial Monitor market, directly elevating the volume of units needed for mass campaigns. As international health bodies intensify efforts to address preventable diseases in remote areas, the logistical demand for temperature verification on individual vials increases to ensure safety during transport. This surge is illustrated by large-scale interventions; for example, Gavi, the Vaccine Alliance, announced in November 2024 its support for preventive catch-up campaigns aiming to reach up to 100 million children with measles-containing vaccines across 24 countries, a mobilization that requires millions of VVM-tagged units to guarantee potency at the point of delivery.

Concurrently, the implementation of stringent cold chain regulatory standards is reshaping market requirements by mandating rigorous temperature oversight alongside infrastructure upgrades. Strengthening the cold chain in developing regions establishes a prerequisite for advanced monitoring tools that can function reliably within improved systems to minimize spoilage. According to the UNICEF Supply Annual Report 2023, published in April 2024, the agency delivered $25 million in cold chain equipment to over 30 countries through its partnership with the Africa Centres for Disease Control and Prevention. These investments highlight a focus on quality assurance, which is critical given broader coverage gaps; the World Health Organization noted in July 2024 that the number of 'zero-dose' children receiving no vaccines hit 14.5 million in 2023, highlighting the immense unmet need for reliable vaccine delivery mechanisms.

Market Challenge

The substantial cost and technical complexity associated with manufacturing stable chemical indicators act as a primary constraint on the growth of the Global Vaccine Vial Monitor Market. Producing thermochromic labels that respond precisely to cumulative heat exposure requires advanced chemical engineering, which inherently raises production expenses and creates high barriers to entry for new manufacturers. These elevated operational costs result in higher per-unit prices, making the technology less accessible for cost-sensitive procurement programs in developing regions where budgets are strictly scrutinized. Consequently, the high expense of these monitors often compels stakeholders to limit their usage or pursue alternative quality control methods, thereby reducing overall market penetration.

This cost barrier becomes increasingly restrictive as the volume of pharmaceutical logistics expands globally. As distribution networks scale up, the cumulative financial burden of applying expensive monitoring solutions to millions of additional units becomes a significant deterrent for supply chain decision-makers. According to the International Air Transport Association (IATA), global air cargo demand increased by 11.1% in April 2024 compared to the previous year, signaling a rising volume of freight that requires temperature-controlled handling. This surge in logistical throughput amplifies the impact of high manufacturing costs, as the investment required to monitor this growing number of units stifles the broader adoption of these essential indicators.

Market Trends

The market is evolving with the adoption of IoT-enabled smart vaccine vial monitors, shifting from simple visual color changes to real-time data logging capabilities. These digital indicators transmit critical stability data to cloud platforms, enabling stakeholders to intervene before spoilage occurs and providing granular visibility into the condition of shipments throughout the cold chain. This technological leap improves upon traditional chemical labels by allowing for precise tracking of unit-level integrity. The demand for such automated oversight is rising; according to Zebra Technologies' 'Hospital Vision Study' from May 2024, 84% of non-clinical hospital leaders now prioritize the integration of automated and digitized inventory tracking systems for items administered at patients' bedsides.

Simultaneously, the expansion into non-vaccine temperature-sensitive pharmaceuticals is widening the application scope of monitoring technologies beyond immunization programs. As the industry advances complex biologics and gene therapies, the requirement for rigorous temperature verification extends to a broader category of high-value assets, protecting treatments that are as fragile as vaccines. This diversification drives demand for versatile indicators capable of protecting expensive specialty medicines. The scale of this shift is significant; according to the Healthcare Distribution Alliance (HDA) Research Foundation's report 'The Future of the U.S. Pharmaceutical Cold Chain' from March 2024, the growth of temperature-sensitive products outpaced non-cold chain therapies by 21% between 2018 and 2024.

Key Market Players

  • Cardinal Health Inc
  • Catalent Inc
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • Elpro-Buchs AG
  • EVIGENCE SENSORS Inc
  • Gerresheimer AG
  • Schott AG
  • Thermo Fisher Scientific Inc

Report Scope

In this report, the Global Vaccine Vial Monitor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vaccine Vial Monitor Market, By Type

  • Multi-Dose
  • Single Dose

Vaccine Vial Monitor Market, By Application

  • Preventive Vaccine
  • Therapeutics Vaccine

Vaccine Vial Monitor Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vaccine Vial Monitor Market.

Available Customizations:

Global Vaccine Vial Monitor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vaccine Vial Monitor Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Multi-Dose, Single Dose)
    • 5.2.2. By Application (Preventive Vaccine, Therapeutics Vaccine)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Vaccine Vial Monitor Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vaccine Vial Monitor Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Vaccine Vial Monitor Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Vaccine Vial Monitor Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Vaccine Vial Monitor Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Vaccine Vial Monitor Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Vaccine Vial Monitor Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Vaccine Vial Monitor Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Vaccine Vial Monitor Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Vaccine Vial Monitor Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Vaccine Vial Monitor Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vaccine Vial Monitor Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Vaccine Vial Monitor Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Vaccine Vial Monitor Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Vaccine Vial Monitor Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Vaccine Vial Monitor Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Vaccine Vial Monitor Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Vaccine Vial Monitor Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Vaccine Vial Monitor Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Vaccine Vial Monitor Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Vaccine Vial Monitor Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Vaccine Vial Monitor Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Vaccine Vial Monitor Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Vaccine Vial Monitor Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vaccine Vial Monitor Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cardinal Health Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Catalent Inc
  • 15.3. Corning Incorporated
  • 15.4. DWK Life Sciences GmbH
  • 15.5. Elitech Technology, Inc.
  • 15.6. Elpro-Buchs AG
  • 15.7. EVIGENCE SENSORS Inc
  • 15.8. Gerresheimer AG
  • 15.9. Schott AG
  • 15.10. Thermo Fisher Scientific Inc

16. Strategic Recommendations

17. About Us & Disclaimer